Effect of mitoxantrone liposomes on multidrug-resistant breast cancer cells

Anticancer Res. 1999 Jul-Aug;19(4B):3327-31.

Abstract

A major obstacle in efficacy of breast cancer chemotherapy is the emergence of multidrug resistance. We investigated modulation of multidrug resistance by liposome-encapsulated mitoxantrone in a drug resistant human breast MCF7R cell line and the influence of liposome composition. Neutral high phase-transition temperature and anionic low phase-transition temperature phospholipid liposomes, reduced the resistance factor from 142 to 15 and 38, respectively. The higher cytotoxicity obtained with mitoxantrone-encapsulation was not necessarily related to higher intracellular uptake. Our data suggest that liposomes, according to their lipid composition, may alter the P-glycoprotein function by plasma membrane stabilization and modulate multidrug resistance in human cancer.

MeSH terms

  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacology*
  • Breast Neoplasms / pathology*
  • Cell Division / drug effects
  • Drug Carriers
  • Drug Resistance, Multiple*
  • Humans
  • Immunohistochemistry
  • Liposomes
  • Mitoxantrone / metabolism
  • Mitoxantrone / pharmacology*
  • Verapamil / pharmacology

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Liposomes
  • Mitoxantrone
  • Verapamil